The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.20
Bid: 50.40
Ask: 51.20
Change: 0.80 (1.59%)
Spread: 0.80 (1.587%)
Open: 51.00
High: 51.20
Low: 50.00
Prev. Close: 50.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Apr 2016 07:00

RNS Number : 1343V
Renold PLC
14 April 2016
 

Renold plc

("Renold", "the Company" or "the Group")

 

Trading Statement

 

Renold, a leading international supplier of industrial chains and related power transmission products, today issues a trading update ahead of reporting results for the year ended 31 March 2016, on 30 May 2016.

 

Our Interim Results and February 2016 Trading Statement noted a high level of volatility in sales and orders. This volatility continued until the end of the year although its adverse impact moderated slightly. Underlying1 sales for the full year are therefore expected to be around 1% better than forecast in our February Trading Statement (being approximately 9% lower than the prior year). The Chain division was the driver of the improvement in underlying sales, in particular Europe and the Americas, and is expected to finish the year down approximately 7% (previous forecast 8% down).

 

Self-help measures continue to be delivered with a further reduction in our break-even point. Once again the Chain division was the key driver and its adjusted operating profit and return on sales will exceed the prior year.

 

As a result of the slightly better than expected sales and ongoing cost reductions, the Board now expects that the Group's underlying Adjusted2 Return on Sales3 will be maintained at 8.6%, the same level as the prior year. Adjusted operating profit will therefore be ahead of current market expectations of £13.5m. The benefit to Adjusted Earnings Per Share will be further enhanced by savings in financing costs and the estimated tax rate applicable in the year.

 

Integration of the newly acquired Aventics Tooth Chain business continues to proceed smoothly with some synergies already being delivered in the fourth quarter.

 

Net debt at the year end, including the impact of the acquisition, was also slightly better than market expectations and resulted in a leverage ratio4 of around 1.20x. This remains comfortably within our covenant limit of 2.5x.

 

Robert Purcell, Chief Executive of Renold, said:

 

"We continue to make good progress in delivering our STEP 2020 Strategic Plan. This has allowed us to maintain our operating margins despite a sizeable reduction in underlying sales. Whilst we remain cautious on the outlook for sales growth due to the continuing volatility in international industrial end markets, we continue to invest time and resources in projects to support the delivery of our medium term STEP 2020 strategic objective of achieving mid-teens operating margins."

 

There have been no other significant changes in the position of the Company since the publication of the Trading Update on 10 February 2016.

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates.

(2) Adjusted items exclude exceptional items, the costs of administering closed defined benefit pension schemes, the amortization of acquired intangibles and any associated tax thereon.

(3) Return on Sales is the ratio of operating profit to sales, expressed as a percentage.

(4) Leverage ratio is calculated as Net Debt divided by Adjusted EBITDA

 

14 April 2016

 

 

ENQUIRIES:

Renold plc

Tel: 0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Group Finance Director

Arden Partners (Broker)

Tel: 020 7614 5917

Chris Hardie

Instinctif Partners (Public Relations)

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers, end users and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRSEIVLIR
Date   Source Headline
18th Jun 20198:00 amRNSAnnual Report and Accounts
17th Jun 201912:07 pmRNSSecond Price Monitoring Extn
17th Jun 201912:02 pmRNSPrice Monitoring Extension
7th Jun 20198:05 amRNSAdmission to trading on AIM
4th Jun 20195:30 pmRNSRenold
3rd Jun 201911:30 amRNSSchedule One update - Renold plc
3rd Jun 20197:00 amRNSTimetable update
28th May 20197:00 amRNSFinal Results
8th May 20191:54 pmRNSResult of General Meeting
8th May 201911:30 amRNSSchedule 1 - Renold Plc
11th Apr 20192:42 pmRNSPosting of shareholder circular
11th Apr 20197:01 amRNSTrading Update
11th Apr 20197:00 amRNSProposed move from Official List to AIM
1st Apr 20197:00 amRNSExtension of Banking Facilities
4th Feb 20198:00 amRNSBlock listing Interim Review
28th Jan 201912:53 pmRNSHolding(s) in Company
16th Nov 20182:39 pmRNSHolding(s) in Company
16th Nov 20182:38 pmRNSHolding(s) in Company
16th Nov 20182:35 pmRNSHolding(s) in Company
15th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 20187:01 amRNSAppointment of Non-Executive Director
14th Nov 20187:00 amRNSHalf-year Report
11th Oct 20187:00 amRNSTrading Update
2nd Oct 20187:00 amRNSAppointment of Broker
2nd Aug 20189:00 amRNSBlock listing Interim Review
18th Jul 20181:26 pmRNSResult of AGM
18th Jul 20187:00 amRNSAGM Statement
14th Jun 20182:09 pmRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAnnual Report and Accounts
8th Jun 201812:49 pmRNSGrant of Awards - Performance Share Plan
31st May 20182:54 pmRNSDirector/PDMR Shareholding
31st May 20182:46 pmRNSDirector/PDMR Shareholding
31st May 201810:05 amRNSDirector/PDMR Shareholding
31st May 20188:47 amRNSDirector/PDMR Shareholding
30th May 20188:38 amRNSDirector/PDMR Shareholding
29th May 20187:00 amRNSFinal Results
25th Apr 201810:07 amRNSHolding(s) in Company
24th Apr 201810:06 amRNSHolding(s) in Company
20th Apr 20187:00 amRNSNotice of Results
19th Apr 20183:16 pmRNSHolding(s) in Company
19th Apr 20188:41 amRNSHolding(s) in Company
18th Apr 20189:02 amRNSHolding(s) in Company
10th Apr 20189:55 amRNSHolding(s) in Company
9th Apr 201810:21 amRNSHolding(s) in Company
3rd Apr 201810:46 amRNSHolding(s) in Company
9th Mar 20187:00 amRNSTrading Update
6th Feb 20184:35 pmRNSPrice Monitoring Extension
2nd Feb 20188:00 amRNSBlock listing Interim Review
14th Nov 20177:00 amRNSHalf-year Report
26th Oct 20173:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.